Geron
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Geron and other ETFs, options, and stocks.About GERN
Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies.
GERN Key Statistics
Stock Snapshot
The current Geron(GERN) stock price is $1.66, with a market capitalization of 1.06B. The stock trades at a price-to-earnings (P/E) ratio of -11.58.
On 2026-04-01, Geron(GERN) stock moved within a range of $1.48 to $1.66. With shares now at $1.66, the stock is trading +12.1% above its intraday low and 0.0% below the session's peak.
Trading activity shows a volume of 26.46M, compared to an average daily volume of 19.84M.
Over the past 52 weeks, Geron(GERN) stock has traded between a high of $2.01 and a low of $1.04.
Over the past 52 weeks, Geron(GERN) stock has traded between a high of $2.01 and a low of $1.04.
GERN News
Advertisement Event context and recent price performance With no specific news event flagged, Geron (GERN) has still been on investors’ radar after a 9.1% one...
Geron Corporation (NasdaqGS:GERN) has appointed Patricia S. Andrews and Constantine Chinoporos to its Board of Directors. Both appointees bring senior biopharm...
Geron ( (GERN) ) has issued an announcement. On March 25, 2026, Geron Corporation’s board elected industry veterans Patricia S. Andrews and Constantine Chinopo...
Analyst ratings
67%
of 6 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.